-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Sorrento Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- Sorrento Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$95.2M, a 56.5% increase year-over-year.
- Sorrento Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$548M, a 4.64% decline year-over-year.
- Sorrento Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$573M, a 33.7% decline from 2021.
- Sorrento Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$428M, a 43.5% decline from 2020.
- Sorrento Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$298M, a 2.19% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)